InsidersTradesSigma
Track the ATH stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the authority of ASX. Operating in the Health Care sector, ATH has recorded 1 insider filings. Market capitalisation: €130.5m. The latest transaction was disclosed on 23 April 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY). Every trade is accessible without an account.
Analysts rate ATH Strong Buy (bullish), based on 2 analysts. Average price target: A$2.28.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration